InChI=1S/C20H28O2/c1- 15(8- 6- 9- 16(2) 14- 19(21) 22) 11- 12- 18- 17(3) 10- 7- 13- 20(18,4) 5/h6,8- 9,11- 12,14H,7,10,13H2,1- 5H3,(H,21,22) /b9- 6+,12- 11+,15- 8- ,16- 14+ |
SHGAZHPCJJPHSC-ZVCIMWCZSA-N |
CC(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C\C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
retinoid X receptor agonist
An agonist that selectively binds to and activates a retinoid X receptor.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via retinoic acid )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
keratolytic drug
A drug that softens, separates, and causes desquamation of the cornified epithelium or horny layer of skin. Keratolytic drugs are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
|
|
View more via ChEBI Ontology
alitretinoína
|
ChEBI
|
alitrétinoïne
|
ChEBI
|
alitretinoinum
|
ChEBI
|
(2E,4E,6Z,8E)- 3,7- dimethyl- 9- (2,6,6- trimethyl- 1- cyclohexen- 1- yl)- 2,4,6,8- nonatetraenoic acid
|
IUPAC
|
(7E,9Z,11E,13E)-retinoic acid
|
ChEBI
|
9(Z)-Retinoic acid
|
ChemIDplus
|
9-cis-Tretinoin
|
ChemIDplus
|
Alitretinoin
|
KEGG DRUG
|
Panretin
|
DrugBank
|
Panretyn
|
DrugBank
|
2057222
|
Reaxys Registry Number
|
Reaxys
|
5300-03-8
|
CAS Registry Number
|
ChemIDplus
|
|